Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends

Standard

Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. / Baldomero, Helen; Aljurf, Mahmoud; Zaidi, Syed Z A; Hashmi, Shahrukh K; Ghavamzadeh, Ardeshir; Elhaddad, Alaa; Hamladji, Rose-Marie; Ahmed, Parvez; Torjemane, Lamia; Abboud, Miguel; Tbakhi, Abdelghani; Khabori, Murtadha Al; El Quessar, Asma; Bazuaye, Nosa; Bekadja, Mohamed Amine; Adil, Salman; Fahmy, Omar; Ramzi, Mani; Ibrahim, Ahmed; Alseraihy, Amal; Ben Abdejalil, Nour; Sarhan, Mahmoud; Huneini, Mohammed Al; Mahmal, Lahoucine; ElSolh, Hassan; Hussain, Fazal; Nassar, Amr; Al-Hashmi, Hani; Hamidieh, Amir Ali; Pasquini, Marcelo; Kodera, Yoshihisa; Kröger, Nicolaus; Mohty, Mohamed; Jaimovich, Gregorio; Rolon, Juliana Martinez; Paulson, Kristjan; Greinix, Hildegard; Weisdorf, Daniel; Horowitz, Mary; Nunez, José; Gratwohl, Alois; Passweg, Jacob; Koh, Mickey; Szer, Jeff; Niederwieser, Dietger; Novitzky, Nicolas; East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT).

In: BONE MARROW TRANSPL, Vol. 54, No. 3, 03.2019, p. 402-417.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Baldomero, H, Aljurf, M, Zaidi, SZA, Hashmi, SK, Ghavamzadeh, A, Elhaddad, A, Hamladji, R-M, Ahmed, P, Torjemane, L, Abboud, M, Tbakhi, A, Khabori, MA, El Quessar, A, Bazuaye, N, Bekadja, MA, Adil, S, Fahmy, O, Ramzi, M, Ibrahim, A, Alseraihy, A, Ben Abdejalil, N, Sarhan, M, Huneini, MA, Mahmal, L, ElSolh, H, Hussain, F, Nassar, A, Al-Hashmi, H, Hamidieh, AA, Pasquini, M, Kodera, Y, Kröger, N, Mohty, M, Jaimovich, G, Rolon, JM, Paulson, K, Greinix, H, Weisdorf, D, Horowitz, M, Nunez, J, Gratwohl, A, Passweg, J, Koh, M, Szer, J, Niederwieser, D, Novitzky, N & East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT) 2019, 'Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends', BONE MARROW TRANSPL, vol. 54, no. 3, pp. 402-417. https://doi.org/10.1038/s41409-018-0275-5

APA

Baldomero, H., Aljurf, M., Zaidi, S. Z. A., Hashmi, S. K., Ghavamzadeh, A., Elhaddad, A., Hamladji, R-M., Ahmed, P., Torjemane, L., Abboud, M., Tbakhi, A., Khabori, M. A., El Quessar, A., Bazuaye, N., Bekadja, M. A., Adil, S., Fahmy, O., Ramzi, M., Ibrahim, A., ... East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT) (2019). Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. BONE MARROW TRANSPL, 54(3), 402-417. https://doi.org/10.1038/s41409-018-0275-5

Vancouver

Bibtex

@article{44e092502e634b3a83c9a3f9e3f3ec61,
title = "Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends",
abstract = "Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006-2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.85%) of all teams were active in 12 of the 68 AFR/EMRO countries. They reported 2.331 (3.3%) of the worldwide 71.036 HSCT, and a transplant rate of 32.8 (TR; HSCT/10 million inhabitants; worldwide 128.5). This reflects still the lowest regional TR despite an increase of 90% since 2006. HSCT activity in AFR/EMRO countries was characterized by a higher use of allogeneic compared to autologous HSCT, an almost exclusive use of family donors, including haploidentical family donors. These findings contrast with the prevalence of autologous over allogeneic HSCT, and a higher frequency of unrelated HSCT in other parts of the world. Of note, the increase by 200% in HSCT for hemoglobinopathies from 2006 to 2013 (72 per year) in the AFR/EMRO region. This reflects the specific role of HSCT for these disease categories with high prevalence and incidence in the AFR/EMRO region. This report provides information for the competent authorities to foster adequate infrastructure. It urges transplant organization to optimize their cooperation.",
keywords = "Journal Article",
author = "Helen Baldomero and Mahmoud Aljurf and Zaidi, {Syed Z A} and Hashmi, {Shahrukh K} and Ardeshir Ghavamzadeh and Alaa Elhaddad and Rose-Marie Hamladji and Parvez Ahmed and Lamia Torjemane and Miguel Abboud and Abdelghani Tbakhi and Khabori, {Murtadha Al} and {El Quessar}, Asma and Nosa Bazuaye and Bekadja, {Mohamed Amine} and Salman Adil and Omar Fahmy and Mani Ramzi and Ahmed Ibrahim and Amal Alseraihy and {Ben Abdejalil}, Nour and Mahmoud Sarhan and Huneini, {Mohammed Al} and Lahoucine Mahmal and Hassan ElSolh and Fazal Hussain and Amr Nassar and Hani Al-Hashmi and Hamidieh, {Amir Ali} and Marcelo Pasquini and Yoshihisa Kodera and Nicolaus Kr{\"o}ger and Mohamed Mohty and Gregorio Jaimovich and Rolon, {Juliana Martinez} and Kristjan Paulson and Hildegard Greinix and Daniel Weisdorf and Mary Horowitz and Jos{\'e} Nunez and Alois Gratwohl and Jacob Passweg and Mickey Koh and Jeff Szer and Dietger Niederwieser and Nicolas Novitzky and {East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT)}",
year = "2019",
month = mar,
doi = "10.1038/s41409-018-0275-5",
language = "English",
volume = "54",
pages = "402--417",
journal = "BONE MARROW TRANSPL",
issn = "0268-3369",
publisher = "NATURE PUBLISHING GROUP",
number = "3",

}

RIS

TY - JOUR

T1 - Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends

AU - Baldomero, Helen

AU - Aljurf, Mahmoud

AU - Zaidi, Syed Z A

AU - Hashmi, Shahrukh K

AU - Ghavamzadeh, Ardeshir

AU - Elhaddad, Alaa

AU - Hamladji, Rose-Marie

AU - Ahmed, Parvez

AU - Torjemane, Lamia

AU - Abboud, Miguel

AU - Tbakhi, Abdelghani

AU - Khabori, Murtadha Al

AU - El Quessar, Asma

AU - Bazuaye, Nosa

AU - Bekadja, Mohamed Amine

AU - Adil, Salman

AU - Fahmy, Omar

AU - Ramzi, Mani

AU - Ibrahim, Ahmed

AU - Alseraihy, Amal

AU - Ben Abdejalil, Nour

AU - Sarhan, Mahmoud

AU - Huneini, Mohammed Al

AU - Mahmal, Lahoucine

AU - ElSolh, Hassan

AU - Hussain, Fazal

AU - Nassar, Amr

AU - Al-Hashmi, Hani

AU - Hamidieh, Amir Ali

AU - Pasquini, Marcelo

AU - Kodera, Yoshihisa

AU - Kröger, Nicolaus

AU - Mohty, Mohamed

AU - Jaimovich, Gregorio

AU - Rolon, Juliana Martinez

AU - Paulson, Kristjan

AU - Greinix, Hildegard

AU - Weisdorf, Daniel

AU - Horowitz, Mary

AU - Nunez, José

AU - Gratwohl, Alois

AU - Passweg, Jacob

AU - Koh, Mickey

AU - Szer, Jeff

AU - Niederwieser, Dietger

AU - Novitzky, Nicolas

AU - East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT)

PY - 2019/3

Y1 - 2019/3

N2 - Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006-2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.85%) of all teams were active in 12 of the 68 AFR/EMRO countries. They reported 2.331 (3.3%) of the worldwide 71.036 HSCT, and a transplant rate of 32.8 (TR; HSCT/10 million inhabitants; worldwide 128.5). This reflects still the lowest regional TR despite an increase of 90% since 2006. HSCT activity in AFR/EMRO countries was characterized by a higher use of allogeneic compared to autologous HSCT, an almost exclusive use of family donors, including haploidentical family donors. These findings contrast with the prevalence of autologous over allogeneic HSCT, and a higher frequency of unrelated HSCT in other parts of the world. Of note, the increase by 200% in HSCT for hemoglobinopathies from 2006 to 2013 (72 per year) in the AFR/EMRO region. This reflects the specific role of HSCT for these disease categories with high prevalence and incidence in the AFR/EMRO region. This report provides information for the competent authorities to foster adequate infrastructure. It urges transplant organization to optimize their cooperation.

AB - Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006-2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.85%) of all teams were active in 12 of the 68 AFR/EMRO countries. They reported 2.331 (3.3%) of the worldwide 71.036 HSCT, and a transplant rate of 32.8 (TR; HSCT/10 million inhabitants; worldwide 128.5). This reflects still the lowest regional TR despite an increase of 90% since 2006. HSCT activity in AFR/EMRO countries was characterized by a higher use of allogeneic compared to autologous HSCT, an almost exclusive use of family donors, including haploidentical family donors. These findings contrast with the prevalence of autologous over allogeneic HSCT, and a higher frequency of unrelated HSCT in other parts of the world. Of note, the increase by 200% in HSCT for hemoglobinopathies from 2006 to 2013 (72 per year) in the AFR/EMRO region. This reflects the specific role of HSCT for these disease categories with high prevalence and incidence in the AFR/EMRO region. This report provides information for the competent authorities to foster adequate infrastructure. It urges transplant organization to optimize their cooperation.

KW - Journal Article

U2 - 10.1038/s41409-018-0275-5

DO - 10.1038/s41409-018-0275-5

M3 - SCORING: Journal article

C2 - 30082852

VL - 54

SP - 402

EP - 417

JO - BONE MARROW TRANSPL

JF - BONE MARROW TRANSPL

SN - 0268-3369

IS - 3

ER -